31,968 bottles of diabetes drug in the US recalled for being ‘superpotent’

Macleods drug company USA INC has recalled 31,968 bottles of Pioglitazone complex pills within the United States of America market once the tablet was found to be ‘superpotent’. These tablets are getting used for the treatment of diabetes.

The tablets being recalled are within the strength of 15 mg and are factory-made by Macleods prescription drugs Ltd in its Baddi facility in Himachal Pradesh, social control report of the USFDA same.

The voluntary current category II recall is on account of the merchandise being “superpotent”, it added.

The product was shipped to 8 distributors who might have any distributed the merchandise, the US Food and Drug Administration (USFDA) same.

As per the USFDA, a category II recall is initiated in a very state of affairs, “in that use of or exposure to an offensive product might cause temporary or medically reversible adverse health consequences or wherever the likelihood of great adverse health consequences is remote”.

The tablets are indicated as an adjunct to diet and exercise to boost glycemic management in adults with type 2 diabetes mellitus in multiple clinical settings.